Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-2701 ◽

2007 ◽

Vol 13 (7) ◽

pp. 2023-2029 ◽

Cited By ~ 260

Author(s):

David R. Shaffer ◽

Margaret A. Leversha ◽

Daniel C. Danila ◽

Oscar Lin ◽

Rita Gonzalez-Espinoza ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cell ◽

Circulating Tumor Cell ◽

Cell Analysis ◽

A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

Theranostics ◽

10.7150/thno.34485 ◽

2019 ◽

Vol 9 (10) ◽

pp. 2812-2826 ◽

Cited By ~ 4

Author(s):

Yu Jen Jan ◽

Junhee Yoon ◽

Jie-Fu Chen ◽

Pai-Chi Teng ◽

Nu Yao ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cell ◽

Circulating Tumor Cell ◽

Receptor Signaling ◽

Androgen Receptor Signaling ◽

Circulating Tumor Cell Eradication as an Intermediate Efficacy End Point for Metastatic Castration-Resistant Prostate Cancer: Is There Enough Evidence?

10.1200/jco.2017.76.5487 ◽

2018 ◽

Vol 36 (6) ◽

pp. 525-527 ◽

Cited By ~ 1

Author(s):

Emmanuel S. Antonarakis

Keyword(s):

Prostate Cancer ◽

Tumor Cell ◽

Circulating Tumor Cell ◽

End Point ◽

Circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide post-chemotherapy (phase 3 AFFIRM study).

10.1200/jco.2015.33.15_suppl.5035 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5035-5035 ◽

Cited By ~ 11

Author(s):

Martin Fleisher ◽

Daniel Costin Danila ◽

Karim Fizazi ◽

Mohammad Hirmand ◽

Brian Selby ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cell ◽

Circulating Tumor Cell ◽

Phase 3 ◽

Baseline analysis of circulating tumor cell (CTC) enumeration and androgen receptor (AR) localization in men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY.

10.1200/jco.2015.33.15_suppl.5031 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5031-5031

Author(s):

Scott T. Tagawa ◽

Giuseppe Galletti ◽

Emmanuel S. Antonarakis ◽

Shinsuke Tasaki ◽

Ada Gjyrezi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cell ◽

Circulating Tumor Cell ◽

Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.

10.1200/jco.2016.34.15_suppl.5042 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 5042-5042

Author(s):

David Lorente ◽

David Olmos ◽

Joaquin Mateo ◽

Zafeiris Zafeiriou ◽

Pasquale Rescigno ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cell ◽

Circulating Tumor Cell ◽

Unique patterns of the selection and change in circulating tumor cell (CTC) phenotypes and genotypes by drug class in metastatic castration-resistant prostate cancer (mCRPC).

10.1200/jco.2018.36.15_suppl.5053 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5053-5053

Author(s):

Howard I. Scher ◽

Joseph Schonhoft ◽

Ryon P Graf ◽

Angel E Dago ◽

Jerry Lee ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cell ◽

Drug Class ◽

Circulating Tumor Cell ◽

Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer

Oncotarget ◽

10.18632/oncotarget.6167 ◽

2015 ◽

Vol 6 (39) ◽

pp. 41825-41836 ◽

Cited By ~ 22

Author(s):

Kun Chang ◽

Yun-Yi Kong ◽

Bo Dai ◽

Ding-Wei Ye ◽

Yuan-Yuan Qu ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cell ◽

Tumor Marker ◽

Treatment Effect ◽

Circulating Tumor Cell ◽

Castration Resistant ◽

Cell Enumeration ◽

Marker Detection

The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-16-1224 ◽

2016 ◽

Vol 23 (8) ◽

pp. 1967-1973 ◽

Cited By ~ 19

Author(s):

Glenn Heller ◽

Karim Fizazi ◽

Robert McCormack ◽

Arturo Molina ◽

David MacLean ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cell ◽

Circulating Tumor Cell ◽

Added Value ◽

Castration Resistant ◽

Cell Enumeration

Phenotypic circulating tumor cell (CTC) classifier of genomic instability (GI) associates with improved overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) receiving platinum agents in addition to taxanes

Annals of Oncology ◽

10.1093/annonc/mdx370.039 ◽

2017 ◽

Vol 28 ◽

pp. v285

Author(s):

H. Scher ◽

R.P. Graf ◽

A. Jendrisak ◽

B. McLaughlin ◽

E. Barnett ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Tumor Cell ◽

Genomic Instability ◽

Circulating Tumor Cell ◽

Castration Resistant ◽

Platinum Agents